Researchers launch early-stage trial for nasal flu vaccine
Researchers at St. Louis University reported that an early-stage trial testing an experimental nasal flu vaccine in children and teens began enrolling participants this week.
In the 50-person study, half of the participants will receive the investigational nasal vaccine and the other half will receive an inactive saline solution. All of the study’s participants are slated to receive an intramuscular injection of a quadrivalent seasonal flu vaccine three months following the initial dose of nasal vaccine or placebo.
Get the full story at our sister site, Drug Delivery Business News.
The post Researchers launch early-stage trial for nasal flu vaccine appeared first on MassDevice.
Source: Mass Device - Category: Medical Devices Authors: Sarah Faulkner Tags: Clinical Trials Pharmaceuticals flugen National Institutes of Health (NIH) Source Type: news
More News: Children | Clinical Trials | Medical Devices | National Institutes of Health (NIH) | Study | Vaccines